The Alvin J. Siteman Cancer Center (SCC) leads all cancer research, care, and education efforts at Washington University School of Medicine, Barnes-Jewish Hospital, St. Louis Children’s Hospital, and BJC HealthCare. SCC’s mission is to prevent cancer in the community and transform cancer patient care through scientific discovery. This mission is accomplished through exceptional research, with emphasis on SCC’s four key strengths and scientific pillars: genomics and its application to clinical care; innovation in imaging technologies and their application to cancer diagnosis and patient care; immunology and the enhancement of patient care with unique immune therapies; and prevention to reduce the cancer burden in the patient population we serve.

SCC researchers have successfully conducted paradigm-shifting research to further understand the mechanisms of cancer pathways, speed the conduit from bench to bedside, and implement prevention strategies that impact cancer screening, incidence, and mortality in our catchment area. Progress is made through SCC’s strong research programs, shared resource support, education and training, pilot funding programs, and community outreach. SCC’s Breast Cancer Research, Hematopoietic Development and Malignancy, Mechanisms of Cancer Biology, Oncologic Imaging, Prevention and Control, Solid Tumor Therapeutics, and Tumor Immunology Research Programs promote novel, multidisciplinary cancer research and encourage intra, inter, and cross-institution collaboration. SCC shared resources provide high-quality imaging, genomics, proteomics, immunomonitoring, flow cytometry, informatics, and biostatistics services to SCC’s over 600 members at subsidized rates to facilitate cutting edge science. The translational research and scientific discovery facilitated by our seven multidisciplinary research programs and 11 shared resources has been driven by the needs of patients in our 82-county catchment area throughout Missouri and southern lllinois.  The results of basic laboratory research are rapidly incorporated into treatment advances, which is enhanced by patient access to more than 500 therapeutic clinical trials, including many collaborative efforts with other leading cancer centers throughout the country. 

The profiles listed here only include SCC members with appointments at Washington University  School of Medicine.  To see a complete list of SCC members, please use the SCC List of Researchers.